Adjuvant high-dose therapy with peripheral blood stem cell support for patients with high-risk breast cancer

@article{Hohaus1999AdjuvantHT,
  title={Adjuvant high-dose therapy with peripheral blood stem cell support for patients with high-risk breast cancer},
  author={Stefan Hohaus and Sonja Martin and Andreas Schneeweiss and Maria Teresa Voso and Richard F Schlenk and Diethelm Wallwiener and Gunther Bastert and Rainer Haas},
  journal={Cancer Chemotherapy and Pharmacology},
  year={1999},
  volume={44},
  pages={S13-S17}
}
We report on the efficacy and toxicity of a sequential high-dose therapy with peripheral blood stem cell (PBSC) support in 107 patients with high-risk stage II/III breast cancer. There were 90 patients with more than 9 tumour-positive axillary lymph nodes. An induction therapy of two cycles of ifosfamide (total dose, 7,500 mg/m2) and epirubicin (120 mg/m2… CONTINUE READING